Episode Details

Back to Episodes

Customize your Nootropics!

Episode 175 Published 3 years, 5 months ago
Description

From sick to superhuman? Join Dr. Jeffrey Gladden and Mark Noots in this episode of the Gladden Longevity Podcast. Mark Effinger, also known as Mr. Noots, has had a lifelong passion for neuroscience. Tragedy struck when he faced a health crisis and lost his wife to a painkiller overdose. Determined to make a difference, he founded Nootopia and now serves as the company's Chief Product Officer. With the help of the dedicated team at BiOptimizers and Nootopia, Mark is on a mission to create high-performance, experiential nutritional supplements that can reverse the effects of addiction and disease. Through his tireless efforts, Mark hopes to address these human conditions as effectively and healthily as possible, and he is committed to positively impacting the world and improving the lives of others. This episode discusses sleep, biochemistry and brain optimization, cognitive performance, and Nootropics. They also delve deeper into why longevity without health is folly, about why amplifying cognitive function and state optimization is the key to effective longevity, health, and happiness, and how sleep is the world's most powerful stimulant. Listen to find out more.

Listen to this episode to learn about making 100 the new 30, and living beyond 120!

Dr. Gladden welcomes everyone to the Age Hackers Podcast powered by Gladden Longevity. (0:40)

Mark shares his history and what he did in the past, including bodybuilding and mountain climbing. (2:37)

Mark explains how he was diagnosed with hypothyroid dysfunction. (3:47)

Dr. Gladden notes that Mark had a lot of detox issues. (5:44)

Mark gives an example of diffusing the room, bringing humor in, and signing a deal. (7:12)

Mark speaks about his experience of creating brainstorming and innovation software. (9:43)

Dr. Gladden points out that exe

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us